Coya Therapeutics
Stock Forecast, Prediction & Price Target
Coya Therapeutics Financial Estimates
Coya Therapeutics Revenue Estimates
Coya Therapeutics EBITDA Estimates
Coya Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $6.00M 0% | Avg: $8.06M Low: $3.49M High: $10.69M avg. 34.39% | Avg: $10.2M Low: $5.37M High: $14.40M avg. 26.44% | Avg: $21.7M Low: $11.44M High: $30.64M avg. 112.74% | Avg: $14.3M Low: $7.53M High: $20.19M avg. -34.10% |
Net Income
% change YoY
| $-4.87M N/A | $-14.67M -201.36% | $-7.98M 45.57% | Avg: $-22.41M Low: $-18.49M High: $-10.26M avg. -180.64% | Avg: $-22.2M Low: $-20.60M High: $-5.17M avg. 0.97% | Avg: $-8.74M Low: $-13.42M High: $-3.36M avg. 60.62% | Avg: $-16.05M Low: $-24.66M High: $-6.18M avg. -83.72% |
EBITDA
% change YoY
| $-4.87M N/A | $-9.78M -100.68% | $-7.90M 19.22% | Avg: $4.03M Low: $1.74M High: $5.34M avg. 151.03% | Avg: $5.1M Low: $2.68M High: $7.20M avg. 26.44% | Avg: $10.85M Low: $5.72M High: $15.32M avg. 112.74% | Avg: $7.15M Low: $3.76M High: $10.09M avg. -34.10% |
EPS
% change YoY
| -$0.5 N/A | -$1.48 -196% | -$0.79 46.62% | Avg: -$1.38 Low: -$1.82 High: -$1.01 avg. -74.26% | Avg: -$1.32 Low: -$2.03 High: -$0.51 avg. 4.11% | Avg: -$0.86 Low: -$1.32 High: -$0.33 avg. 34.84% | Avg: -$1.58 Low: -$2.43 High: -$0.61 avg. -83.72% |
Operating Expenses
% change YoY
| $4.87M N/A | $9.81M 101.46% | $13.90M 41.72% | Avg: $8.68M Low: $3.76M High: $11.51M avg. -37.56% | Avg: $10.97M Low: $5.78M High: $15.50M avg. 26.44% | Avg: $23.35M Low: $12.31M High: $32.98M avg. 112.74% | Avg: $15.39M Low: $8.11M High: $21.73M avg. -34.10% |
FAQ
What is Coya Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -50.69% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -18.49M, average is -22.41M and high is -10.26M.
What is Coya Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 34.87% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $3.49M, average is $8.06M and high is $10.69M.
What is Coya Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -29.75% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$1.82, average is -$1.38 and high is $-1.01.